Manual article review is required for this article
Manual article review is required for this article
Manual article review is required for this article
The results were being sophisticated by uneven distribution of ApoE4 carriers among placebo and treatment groups, which was because of an EMA ask for during the trial. A subgroup analysis, presented at CTAD, recommended that the treatment gain was not as a result of this imbalance (Nov 2018 convention news).Some medicines are usually not convenient